Antipsychotics associated with weight gain, lower levels of good cholesterol in Alzheimer's patients

Share this article:
Two newer antipsychotic drugs have negative side effects in Alzheimer's patients. Both promote weight gain and one lowers levels of HDL "good" cholesterol, according to a new study.

The drugs associated with weight gain are olanzapine and quetiapine. Those who took olanzapine showed both weight gain and declines in HDL cholesterol. The study was to be published online April 15 in the American Journal of Psychiatry.

"These findings are especially troubling, because antipsychotics are associated with a higher risk of death and cerebrovascular adverse events in patients with dementia," according to principal investigator Dr. Lon S. Schneider in an American Psychiatric Association news release. "They're often used to minimize disruptive symptoms (such as psychosis or agitation), but patients should be monitored more closely."

Share this article:

More in News

Skilled nursing facilities with poor quality ratings do not readmit more patients to hospitals, researchers find

Skilled nursing facilities with poor quality ratings do ...

Low-quality and high-quality skilled nursing facilities readmit about the same proportion of residents to hospitals, suggest research findings recently published in the American Journal of Medical Quality.

Cipro and related antibiotics increase MRSA risk in long-term care facilities, study ...

Long-term care residents on a fluoroquinolone antibiotic such as Cipro are at an increased risk for methicillin-resistant Staphylococcus aureus, researchers in France have found.

Jonathan Blum, who oversaw long-term care reforms, resigns as head of Medicare

The nation's top Medicare official, Jonathan Blum, is leaving his post next month, news outlets reported Tuesday. Blum became a familiar figure to long-term care providers through Open Door Forum calls and other outreach efforts during his five-year tenure, as he guided implementation of Medicare ...